MS FIRST - utilising a longitudinal, prospective, comparative drug safety module for use in everyday MS clinical practice to evaluate and track incidence and characteristics of safety outcomes in MS patients on therapy over the long term

J. Haartsen, T. Spelman, J. Baker, S. Agland, J. Lechner-Scott, T. Burke, S. Vucic, L. Rath, O. Skibina, M. Toubia, M. Slee, B. Taylor, S. Mac Gregor, A. M. Oconnell, M. Barnett, S. Baker, M. Sharma, S. Hodgkinson, S. Walters, A. KermodeW. Hayes, E. Butler, N. Sheuy, C. Shaw, R. Portley, T. Hardy, I. L. Tan, H. Butzkueven

Research output: Contribution to journalAbstract/Meeting Abstractpeer-review

Original languageEnglish
Pages (from-to)403-404
Number of pages2
JournalMultiple Sclerosis Journal
Publication statusPublished - Oct 2017
Event7th Joint European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS)-Americas-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ACTRIMS) - Paris, France
Duration: 25 Oct 201728 Oct 2017

Cite this